Archive · 27 Jul 2026
Naman Gosalia Advances Cardiovascular Prevention at UN AI Dialogue
Naman Gosalia, the founder of AnginaX, is working to make cardiovascular disease prevention a regular part of healthcare.
He recently spoke at the United Nations Global AI Governance Dialogue in Geneva, Switzerland.
Gosalia believes that while we have a lot of scientific knowledge about heart disease, it's not being used effectively in everyday healthcare.
He thinks AI can help make prevention a continuous process, like measuring blood pressure.
Gosalia has been working with doctors, healthcare institutions, and international organizations to make this happen.
He hopes that in the future, AI will be used responsibly to prevent millions of heart attacks and strokes before they occur.
Naman Gosalia, founder of AnginaX, advocates for continuous cardiovascular prevention in routine healthcare.
He participated in the United Nations Global AI Governance Dialogue in Geneva, Switzerland.
Gosalia believes AI can help operationalize cardiovascular prevention through evidence-based clinical workflows.
He emphasizes the importance of making prevention a continuous process, not just an occasional screening.
Gosalia's work focuses on integrating modern cardiovascular science into routine healthcare to prevent heart attacks and strokes.
- Who
- Naman Gosalia, Founder of AnginaX
- What
- Advocating for cardiovascular prevention through AI governance
- When
- During the United Nations Global AI Governance Dialogue
- Where
- Geneva, Switzerland
- Why
- To make cardiovascular prevention a continuous part of routine healthcare
Proactive Prevention Advocates
Traditional Healthcare Systems
Prevention Integration
Proactive Prevention Advocates
Cardiovascular prevention should be a continuous part of routine healthcare, integrated into everyday medical practices.
Traditional Healthcare Systems
Prevention is often treated as an occasional screening event rather than a continuous process.
AI in Healthcare
Proactive Prevention Advocates
AI should be used to operationalize cardiovascular prevention through evidence-based clinical workflows and interoperability.
Traditional Healthcare Systems
AI implementation in healthcare must be carefully managed to ensure patient safety and clinical accountability.
- Annual Cardiovascular Deaths
- Nearly 20 million
- Event
- United Nations Global AI Governance Dialogue
- Location
- Geneva, Switzerland
- Organization
- AnginaX
- Founder
- Naman Gosalia
- Key Focus
- Cardiovascular disease prevention
- Philosophy
- Continuous cardiovascular prevention as routine healthcare
- AI Governance
- Responsible implementation of AI in healthcare